Radiation for Mesothelioma: Could Proton Therapy Be the Answer?

Researchers at the Maryland Proton Therapy Treatment Center say that a highly-targeted version of proton beam radiation could be the future of radiotherapy for malignant plural mesothelioma.

Advanced Oncotherapy (LON:AVO), is developing a unique, fully integrated, proton therapy system. The LIGHT System is expected to be the first commercially available linear proton accelerator for medical treatment of cancer patients.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    Advanced Oncotherapy Plc

    More articles like this

    Advanced Oncotherapy Plc

    Advanced Oncotherapy Update on Distribution Agreement

    Advanced Oncotherapy PLC (LON:AVO), the developer of next-generation proton therapy systems for cancer treatment, has today announced that discussions between Yantai Cipu, through its affiliated entity Liquid Harmony, and a major medical equipment and pharmaceutical distribution company

    Hardman & Co

    Advanced Oncotherapy Confidence greatly boosted

    Advanced Oncotherapy Plc (LON:AVO) is focused on delivering a more affordable, novel, proton-based radiotherapy system, based on technology developed originally at the world-renowned CERN. Major technical milestones were achieved in 2017 and the company remains on

    Advanced Oncotherapy Plc

    Hardman & Co: Advanced Oncotherapy PLC (LON:AVO)

    Confidence greatly boosted AVO is focused on delivering a more affordable, novel, proton-based radiotherapy system, based on technology developed originally at the world-renowned CERN. Major technical milestones were achieved in 2017 and the company remains on track with its

    Advanced Oncotherapy Plc

    “Amazing” recovery of Ashya King

    A young boy with a brain tumour whose parents sparked a Europe-wide manhunt when they whisked him away from hospital has shown the remarkable recovery he’s making. Ashya King revealed to TV presenter Stacey Solomon that

    Advanced Oncotherapy Plc

    Advanced Oncotherapy Director purchased more shares in the company

    Advanced Oncotherapy (LON:AVO), the developer of next-generation proton therapy systems for cancer treatment, told DirectorsTalk that yesterday Dr Enrico Vanni, Non-Executive Director of the Company purchased 40,000 ordinary shares of 25 pence in the Company at

    Advanced Oncotherapy Plc

    Advanced Oncotherapy Technological update

    Advanced Oncotherapy Plc (LON:AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that it remains on schedule with the development of the first LIGHT system, as per the timetable provided to shareholders on 6

    Hardman & Co

    Advanced Oncotherapy Consolidating market

    Advanced Oncotherapy Plc (LON:AVO) is focused on delivering a more affordable, novel, proton-based radiotherapy system, based on technology originally developed at the world-renowned CERN. Major milestones have been achieved in 2017 and the company remains on

    Advanced Oncotherapy Plc

    Advanced Oncotherapy gets boost from stalwart investor

    How lucky Advanced Oncotherapy PLC (LON:AVO) has been in its investors. Last week the Aim-quoted pioneer of proton beam cancer treatment signed a breakthrough agreement with Yantai CIPU, a Chinese medical technology group, to sell its

    Hardman & Co

    Advanced Oncotherapy Distribution agreement and capital increase

    Advanced Oncotherapy Plc (LON:AVO) is focused on delivering a more affordable, novel, proton-based radiotherapy system, based on technology originally developed at the world-renowned CERN. Major milestones have been achieved in 2017 and the company remains on

    Hardman & Co

    Advanced Oncotherapy Technology advances & stronger balance sheet

    Advanced Oncotherapy Plc (LON:AVO) is focused on delivering a more affordable, novel, proton-based radiotherapy system, based on technology originally developed at the world renowned CERN. The company is entering an exciting stage with construction of its